Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Testicular Injury and Oligospermia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating cultured allogeneic umbilical cord-derived mesenchymal stem cells for testicular injury and oligospermia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oligospermia
• Testicular Injury

Drugs mentioned

• Umbilical cord-derived mesenchymal stem cells (cultured, allogeneic) (Mesenchymal stem cells)

Snippet

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Testicular Injury, Oligospermia | Phase 1 | Status: WITHDRAWN